Related Experiment Videos

Clinical trial in nephrology at hard end point?

Dick de Zeeuw, Pieter A de Graeff

Journal of the American Society of Nephrology : JASN

|January 30, 2004

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension Status.

Kidney international reports·2026

Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses.

Diabetes, obesity & metabolism·2026

Cystatin C Confirms the Canagliflozin eGFR Slope Benefit in CANPIONE.

Kidney international reports·2026

A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope.

Kidney international·2024

Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease : A Systematic Review and Retrospective Individual Participant-Level Meta-analysis of Clinical Trials.

Annals of internal medicine·2024

Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial.

Diabetes, obesity & metabolism·2024

See all related articles